A recent study from Taiwan revealed a concerning link between newly detected diabetes mellitus and a higher prevalence of ...
Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks and strokes in survivors.
Discover how regular exercise can strengthen your heart, regulate blood sugar and lower heart disease risk for those with ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.
Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...